Skip to Main Content

Author Details

Karoly Szuhai
Leiden University Medical Center
1997
215
52
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36939112No NFATC2 fusion in simple bone cyst of the jaw.Histopathology2023
37695550VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation.Cancer Immunol Res2023
37976651Generation of four gene-edited human induced pluripotent stem cell lines with mutations in the ATM gene to model Ataxia-Telangiectasia.Stem Cell Res2023
36951952Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis.JCI Insight2023
36788065Psammomatoid Ossifying Fibroma Is Defined by SATB2 Rearrangement.Mod Pathol2023
36504457A novel colony-stimulating factor 1 (CSF1) translocation  involving human endogenous retroviral element in a tenosynovial giant cell tumor.Genes Chromosomes Cancer2023
34921235A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target.Lab Invest2022
35443852Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches.Expert Opin Ther Targets2022
35650682GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics.Am J Surg Pathol2022
35776704The impact of monosomies, trisomies and segmental aneuploidies on chromosomal stability.PLoS One2022
35776127Large-scale genome editing based on high-capacity adenovectors and CRISPR-Cas9 nucleases rescues full-length dystrophin synthesis in DMD muscle cells.Nucleic Acids Res2022
36139642MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells.Cancers (Basel)2022
36171445Identification of stable housekeeping genes for induced pluripotent stem cells and -derived endothelial cells for drug testing.Sci Rep2022
36230631Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of Bone.Cancers (Basel)2022
34081036Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors: A Common Genomic Abnormality in Vascular Malformation/Hemangioma and Simple Bone Cyst.Am J Surg Pathol2021
33653978FOS Rearrangement and Expression in Cementoblastoma.Am J Surg Pathol2021
33807947Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics.Cancers (Basel)2021
34499650Transcriptional progression during meiotic prophase I reveals sex-specific features and X chromosome dynamics in human fetal female germline.PLoS Genet2021
34707097Breast cancer dormancy is associated with a 4NG1 state and not senescence.NPJ Breast Cancer2021
34381187Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases.Mod Pathol2021
34127734Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.Sci Rep2021
33959300Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature.Oxf Med Case Reports2021
34225547Gene fusions in vascular tumors and their underlying molecular mechanisms.Expert Rev Mol Diagn2021
32542935Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.J Pathol Clin Res2020
31728625Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.Virchows Arch2020
31857684Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.Mod Pathol2020
31799604Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking.Nucleic Acids Res2020
31768625Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.Virchows Arch2020
33377124Vascular Tumor Recapitulated in Endothelial Cells from hiPSCs Engineered to Express the <i>SERPINE1-FOSB</i> Translocation.Cell Rep Med2020
33260481Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma.Cancers (Basel)2020
32920118Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma.Biochim Biophys Acta Mol Basis Dis2020
32272316Attenuated isolated 3' signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC.Lung Cancer2020
30572118Molecular Pathology of Bone Tumors.J Mol Diagn2019
31733439Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts.Stem Cell Res2019
30152874Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?Histopathology2019
31433233[Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].Orv Hetil2019
30895378DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.J Cancer Res Clin Oncol2019
30785874Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.PLoS Comput Biol2019
29249267Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture.Virology2018
29863301Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches.Chembiochem2018
30096382High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.J Mol Diagn2018
30144205Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides.Genes Chromosomes Cancer2018
30139549Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing.J Mol Diagn2018
30524904PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy.Oncoimmunology2018
29631426[Multiplex ligation-dependent probe amplification in oncohematological diagnostics and research].Orv Hetil2018
29511030Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.Clin Cancer Res2018
29535719Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction.Front Immunol2018
27870946Conserved hierarchical gain of chromosome 4 is an independent prognostic factor in high hyperdiploid pediatric acute lymphoblastic leukemia.Leuk Res2017
31305775Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.Nat Commun2017
28081266Human Extravillous Trophoblasts Penetrate Decidual Veins and Lymphatics before Remodeling Spiral Arteries during Early Pregnancy.PLoS One2017
  • 1 - 50 of 215

Recommended Authors

Julien Masliah-Planchon
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 8
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Alessandro Raso
Giannina Gaslini Institute
Career Start Year 2003
Number of shared co-authors 3
Fady M Mikhail
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 1
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 21
Marilyn M Li
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 1
Piergiorgio Modena
S. Anna General Hospital
Career Start Year 2000
Number of shared co-authors 6
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 14
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 2
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 5
Gordana Raca
Children's Hospital Los Angeles
Career Start Year 1997
Number of shared co-authors 2
Jane Bayani
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 3
Javed Khan
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 24
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 2
Nalan Gokgoz
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1993
Number of shared co-authors 16
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 3
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 2
Julie M Gastier-Foster
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 13
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 9
Nallasivam Palanisamy
Vattikuti Urology Institute
Career Start Year 1990
Number of shared co-authors 1
Thomas Ried
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 3
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Peter Lichter
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 19
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 19
Jeremy A Squire
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 5
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Career Start Year 1978
Number of shared co-authors 14
Javier Ben??tez
Instituto de Salud Carlos III
Career Start Year 1975
Number of shared co-authors 7
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 16

Collaborators

Don??t Alp??r
Semmelweis University
Co-authored papers 8
Hailiang Mei
Leiden University Medical Center
Co-authored papers 6
Christine L Mummery
Leiden University Medical Center
Co-authored papers 5
Daniel Baumhoer
Co-authored papers 5
Johan T den Dunnen
Leiden University Medical Center
Co-authored papers 4
Piero Picci
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 4
Bernadette Liegl-Atzwanger
Diagnostic and Research Institute of Pathology, Medical University of Graz
Co-authored papers 4
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers 4
Massimo Serra
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 3
Nigel P Carter
4Wellcome Trust Sanger Institute
Co-authored papers 3
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 3
Uta Dirksen
University Hospital Essen, West German Cancer Center
Co-authored papers 3
Heike Fiegler
Co-authored papers 3
Ola Myklebost
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 3
Katia Scotlandi
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 3
Roberto Tirabosco
University College London, UCL Cancer Institute
Co-authored papers 3
B. E. Snaar-Jagalska
Institute of Biology, Leiden University
Co-authored papers 3
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers 2
Fernanda Amary
Royal National Orthopaedic Hospital
Co-authored papers 2
Gert-Jan B van Ommen
Co-authored papers 2
Wietske van der Ent
University of Oslo
Co-authored papers 2
Andreas Leithner
Medical University of Graz
Co-authored papers 2
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers 2
Luca Sangiorgi
Department of Rare Skeletal Disorders - IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 2
Oscar M Rueda
University of Cambridge
Co-authored papers 2
Dina Halai
Royal National Orthopaedic Hospital National Health Service Trust
Co-authored papers 2
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 2
Mats Nilsson
Stockholm University
Co-authored papers 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
Cristina R Antonescu
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Release 1.2